Researchers from the Keck School of Medicine of USC discovered that when cells are under stress, a key protein can travel to the nucleus and reprogram cells to migrate and become more invasive.
ArteraAI has validated its first multimodal artificial intelligence digital pathology-based post-radical prostatectomy biomarker for stratifying risk of metastasis and identifying differential absolute benefit for the addition of hormone therapy to salvage radiation therapy in radical prostatectomy patients with biochemical recurrence.
